The influential UK medical magazine The Lancet has published an expert review which gives a positive report on the effectiveness of the Kazakh produced Covid vaccine...
EMA’s safety committee has concluded today (7 April) that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria...
Today’s (29 January) Commission announcement on a temporary transparency and authorization mechanism on vaccines backfired when it became clear that it could potentially trigger the safeguarding...
Over the last few weeks, EMA has made good progress on the assessment of the marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine. A continuous dialogue...
EMA has received an application for conditional marketing authorization (CMA) for BNT162b2, a COVID‑19 mRNA vaccine developed by BioNTech and Pfizer. The assessment of BNT162b2 will proceed...
EU leaders met via video conference this evening (19 December) to discuss the EU response to the COVID-19 pandemic. European Commission President Ursula von der Leyen...
In a statement this afternoon (16 November), President of the European Commission Ursula von der Leyen, announced that the European Commission has reached a new agreement...
